CLINICAL_TRIALS
trial_result
· 2025-03-21
Clinical Trial Update: Target Engagement and Response to Oxytocin [Phase 4]
Summary
A Phase 4 trial update evaluating oxytocin for schizophrenia, focusing on target engagement and clinical response. The study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED